MRC1 and inflammatory bowel disease: Assessment of CD206+CD68+ macrophages (a putative tissue-repair cell) revealed reduced numbers in biopsies from patients with IBD [5], but it was not determined if this was due to lack of recruitment, conversion to another phenotype (or loss of CD206 and/or CD68 expression), or increased in situ cell death.